Browse By Person: Adams, Mark
|Up a level|
Group by: Item Type | Date
Number of items: 15.
Ramsay, Andrew J., Reid, Janet C., Adams, Mark N., Samaratunga, Hemamali, Dong, Ying, Clements, Judith A., et al. (2008) Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs). Biological Chemistry, 389(6), pp. 653-668.
He, Yaowu, Wortmann, Andreas, Burke, Leslie, Reid, Janet, Adams, Mark, Abdul-Jabbar, Ibtissam, et al. (2010) Proteolysis-induced N-terminal ectodomain shedding of the integral membrane glycoprotein CUB domain-containing protein 1 (CDCP1) is accompanied by tyrosine phosphorylation of its C-terminal domain and recruitment of Src and PKC? Journal of Biological Chemistry, 285(34), pp. 26162-26173.
Adams, Mark, Ramachandran, Rithwik, Yau, Mei-Kwan, Suen, Jacky, Fairlie, David, Hollenberg, Morley, et al. (2011) Structure, function and pathophysiology of protease activated receptors. Pharmacology and Therapeutics, 130(3), pp. 248-282.
Adams, Mark, Christensen, Melinda, He, Yaowu, Waterhouse, Nigel, & Hooper, John (2011) The role of palmitoylation in signalling, cellular trafficking and plasma membrane localization of protease-activated receptor-2. PLoS ONE, 6(11), pp. 1-14.
Adams, Mark N. (2012) In vitro and in vivo studies on protease-activated receptor-2. PhD thesis, Queensland University of Technology.
Adams, Mark N., Leong, Vincent, Paquet, Nicolas, Bolderson, Emma, Fennell, Dean A., O'Byrne, Kenneth, et al. (2013) HSSB1: An essential regulator of genomic integrity in lung cancer. In 15th World Conference on Lung Cancer, 27-30 October 2013, Sydney, NSW.
Jekimovs, Christian, Bolderson, Emma, Suraweera, Amila, Adams, Mark, O'Byrne, Kenneth J., & Richard, Derek J. (2014) Chemotherapeutic compounds targeting the DNA double-strand break repair pathways : the good, the bad, and the promising. Frontiers in Oncology, 4(86).
Dong, Ying, Harrington, Brittney S., Adams, Mark N., Wortmann, Andreas, Stephenson, Sally-Anne, Lisle, Jessica E., et al. (2014) Activation of membrane-bound proteins and receptor systems: A link between tissue kallikrein and the KLK-related peptidases. Biological Chemistry, 395(9), pp. 977-990.
Burgess, Joshua T., Croft, Laura V., Wallace, Nathan C., Stephenson, Sally-Anne, Adams, Mark N., Ashton, Nicholas W., et al. (2014) DNA repair pathways and their therapeutic potential in lung cancer. Lung Cancer Management, 3(2), pp. 159-173.
Adams, Mark N., Ashton, Nicholas W., Paquet, Nicolas, O'Byrne, Kenneth J., & Richard, Derek J. (2014) Mechanisms of cisplatin resistance: DNA repair and cellular implications. In Morais, Christudas (Ed.) Advances in Drug Resistance Research. Nova Science Publishers, New York, pp. 1-37.
Paquet, Nicolas, Adams, Mark N., Leong, Vincent, Ashton, Nicholas W., Touma, Christine, Gamsjaeger, Roland, et al. (2015) hSSB1 (NABP2/ OBFC2B) is required for the repair of 8-oxo-guanine by the hOGG1-mediated base excision repair pathway. Nucleic Acids Research, 43(18), pp. 8817-8829.
Paquet, Nicolas, Adams, Mark N., Ashton, Nicholas W., Touma, Christine, Gamsjaeger, Roland, Cubeddu, Liza, et al. (2016) hSSB1 (NABP2/OBFC2B) is regulated by oxidative stress. Scientific Reports, 6, Article number: 27446.
O'Byrne, K., Adams, M., Burgess, J., & Richard, D. (2016) CDCA3 regulates the cell cycle and modulates cisplatin sensitivity in non-small cell lung cancer. In European Lung Cancer Conference (ELCC 2016), 13 - 16 April 2016, Geneva, Switzerland.
O'Byrne, K., Paquet, N., Box, J.K., Adams, M., & Richard, D. (2016) Examination of EXOSC4 as a new prognostic marker and a novel therapeutic avenue in lung adenocarcinoma. In European Lung Cancer Conference (ELCC 2016), 13 - 16 April 2016, Geneva, Switzerland.
O'Byrne, K.J., Burgess, J., Bolderson, E., Adams, M., Zhang, S-D, & Richard, D. (2016) The overexpression of SASH1 stimulates cell death in lung cancer cells. In European Lung Cancer Conference (ELCC 2016), 13 - 16 April 2016, Geneva, Switzerland.